Evidence map›Paper›PMID 31175012›Full record

ArticleMolecular cell2019

Engineered Ribonucleoprotein Granules Inhibit Translation in Protocells.

Joseph R Simon, Seyed Ali Eghtesadi, Michael Dzuricky, Lingchong You, Ashutosh Chilkoti

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
  18. Article
  19. Engineering synthetic biomolecular condensates.Nature reviews bioengineering · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph R SimonNSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Seyed Ali EghtesadiNSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA.
Michael DzurickyNSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Lingchong YouDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA; Center for Genomic and Computational Biology, Duke University, Durham, NC 27708, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA.
Ashutosh ChilkotiNSF Research Triangle Materials Research Science and Engineering Center, Duke University, Durham, NC 27708, USA; Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA. Electronic address: ashutosh.chilkoti@duke.edu.
Duke University · US

Funding

ELASTIN FUSION PROTEINSR01GM061232 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2000 to 2017
$4.6M
Genetically Encoded Smart Biohybrid MaterialsR35GM127042 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2018 to 2022
$2.2M
NIGMS NIH HHS R01 GM061232NIGMS NIH HHS R35 GM127042
6 · The paper itself

Abstract

Liquid granules rich in intrinsically disordered proteins and RNA play key roles in critical cellular functions such as RNA processing and translation. Many details of the mechanism via which this occurs remain to be elucidated. Motivated by the lacuna in the field and by the prospects of developing de novo artificial granules that provide extrinsic control of translation, we report a bottom-up approach to engineer ribonucleoprotein granules composed of a recombinant RNA-binding IDP that exhibits phase behavior in water. We developed a kinetic model to illustrate that these granules inhibit translation through reversible or irreversible sequestration of mRNA. Within monodisperse droplets capable of transcription and translation, we experimentally demonstrate temporal inhibition of translation by using designer IDPs that exhibit tunable phase behavior. This work lays the foundation for developing artificial granules that promise to further our mechanistic understanding of their naturally occurring counterparts.

Indexed as

Amino Acid SequenceArtificial CellsCytoplasmic GranulesElastinEscherichia coliGene ExpressionIntrinsically Disordered ProteinsModels, BiologicalPeptidomimeticsPhase TransitionPlasmidsProtein BiosynthesisProtein EngineeringRecombinant ProteinsRibonucleoproteinsRNAElastinIntrinsically Disordered ProteinsPeptidomimeticsRecombinant ProteinsRibonucleoproteinsRNARNA, MessengerRNA, recombinant

Identifiers

PMID31175012
PMCPMC6640848
OpenAlexW2948379537

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.